EXEL
Exelixis (EXEL)
$31
About Exelixis (EXEL)
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.
Details
Daily high
$26.66
Daily low
$26.26
Price at open
$26.66
52 Week High
$27.83
52 Week Low
$18.64
Market cap
7.5B
Dividend yield
0.00%
Volume
739,485
Avg. volume
1.7M
P/E ratio
22.53
Exelixis News
Details
Daily high
$26.66
Daily low
$26.26
Price at open
$26.66
52 Week High
$27.83
52 Week Low
$18.64
Market cap
7.5B
Dividend yield
0.00%
Volume
739,485
Avg. volume
1.7M
P/E ratio
22.53